Having trouble viewing this email? View in your browser.
ESCMID Logo

14 May 2019
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

ESCMID Study Group Research Grants 2019 opening soon!

In 2019, ESCMID will support Study Group research projects in the fields of clinical microbiology and infectious diseases. The call to apply for the ESCMID Study Group Research Grants will officially open 17 May 2019 and the deadline for submitting your applications is 17 July 2019, 17:00 CEST.

All information regarding ESCMID Study Group Research funding is available here.

Please carefully read the updated “What you need to apply” section: important changes have been made compared to the previous call.

› Read more

Applications are now being accepted for ESCMID funded Observerships at the ECDC

We hope you take this opportunity to apply until 29. May 2019, 12:00 (CET) for one of the 15 precious observerships at the European Centre for Disease Prevention and Control (ECDC). Please note: This ESCMID funded observership is not only available for Young Scientist Members, also Full Members of ESCMID (below 45 Years) can apply, if they fulfill the eligibility criteria described on the ESCMID website. Use the link below to get directed to the website and submit your application to ESCMID today.  

In case of questions, please contact: observership@escmid.org

› Read more

Guideline highlight:

Consensus statement on antimicrobial de-escalation in critically ill patients: A task force of the European Society of Intensive Care Medicine (ESICM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

The draft version of the "Consensus statement on antimicrobial de-escalation in critically ill patients " has now entered into the public consultation phase. The guideline is a result of the concerted efforts of experts across Europe. The ESCMID members wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedbacks and comments on the manuscript until 11th June 2019.  Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.

› Read more
 

355 session proposals submmitted for ECCMID 2020!

On 17th Aril 2019, ESMID opened a call for session proposals for ECCMID 2020. The call was open to the ECCMID Programme Committee, ESCMID Study Groups, ESCMID affiliated and partner societies and other entities working closely with ESCMID (e.g. EUCIC, EUCAST, EITaF). A total of 355 proposals were submitted: 105 for 1-hour Symposia, 130 for 2-hour Symposia, 47 for Educational Workshops, 36 for Keynote lectures, 37 for Meet-the-Expert sessions. The ECCMID Programme Committee and the ESCMID Education subcommittee are currently evaluating these submissions. At their meeting on June 6-7, the ECCMID Programme Committee will finalise the ECCMID 2020 invited programme.

› Read more
 

GARDP COHERENCE survey

The GARDP COHERENCE survey "COmbination tHERapy to treat sepsis due to carbapenem-resistant Gram negative bacteria in adult and pediatric population: EvideNCE and common practice" is now open and ready for the distribution. General information on the survey:

  • the survey targets all prescribers usually dealing with the treatment of infections due to Carbapenem-resistant bacteria: clinical microbiologists, internal medicine physicians, neonatologists, pediatricians, intensivists;
  • it takes approximatively 15 minutes;
  • it is anonymous. If desired, the respondent can indicate name and full affiliation at the end of the survey in order to be acknowledged in the final online report;
  • it is available in three languages: English, Spanish, French;
  • by completing the survey, there is chance to win a complementary registration fee for the 2020 ECCMID congress in Paris

› Read more
 

Open call to join the CMI editorial team

Clinical Microbiology and Infection (CMI) is looking for an editor to join our editorial team. We are looking for an editor who will deal mainly with clinical studies.   

See the full PDF document here.

› Read more
 

CMI Highlight: Contaminating viral sequences in high-throughput sequencing viromics: a linkage study of 700 sequencing libraries

M Asplund et al. aim to systematically examine a diverse repertoire of laboratory components used to prepare samples for High-throughput sequencing (HTS) in order to identify contaminating viral sequences.

Sample preparation for High-throughput sequencing (HTS) includes treatment with various laboratory components, potentially carrying viral nucleic acids, the extent of which has not been thoroughly investigated. A total of 322 samples of mainly human origin were analysed using eight protocols, applying a wide variety of laboratory components. Several samples (60% of human specimens) were processed by different protocols. In total 712 sequencing libraries were investigated for viral sequence contamination.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.